Published in Arterioscler Thromb Vasc Biol on November 01, 2001
A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucleic Acids Res (2005) 1.00
Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia. Epigenetics (2014) 0.92
Mechanisms of lipase maturation. Clin Lipidol (2010) 0.88
Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects. FEBS Lett (2011) 0.87
Down-regulation of lipoprotein lipase increases ABCA1-mediated cholesterol efflux in THP-1 macrophages. Biochem Biophys Res Commun (2014) 0.84
Overexpression of TGF-ß1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice. PLoS One (2012) 0.81
The common biological basis for common complex diseases: evidence from lipoprotein lipase gene. Eur J Hum Genet (2010) 0.80
ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nat Commun (2016) 0.80
Amelioration of hypertriglyceridemia with hypo-alpha-cholesterolemia in LPL deficient mice by hematopoietic cell-derived LPL. PLoS One (2011) 0.77
Gene expression profiling on global cDNA arrays gives hints concerning potential signal transduction pathways involved in cardiac fibrosis of renal failure. Comp Funct Genomics (2003) 0.75
Generation of retroviruses for the overexpression of cytosolic and mitochondrial glutathione reductase in macrophages in vivo. Cytotechnology (2007) 0.75
MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice. PLoS One (2016) 0.75
Human lipoprotein lipase complementary DNA sequence. Science (1987) 9.50
Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis (1985) 7.61
The sequence of cDNA encoding lipoprotein lipase. A member of a lipase gene family. J Biol Chem (1987) 2.20
Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Atherosclerosis (1987) 1.78
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest (1999) 1.76
Preparation, characterization, and measurement of lipoprotein lipase. Methods Enzymol (1986) 1.73
Structure of the human lipoprotein lipase gene. Biochemistry (1989) 1.72
Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci U S A (1995) 1.56
Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 1.55
Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J Clin Invest (1995) 1.54
Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest (1992) 1.40
Lipoprotein lipase: cellular origin and functional distribution. Am J Physiol (1990) 1.19
Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. J Clin Invest (1992) 1.16
Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice. J Lipid Res (1998) 1.09
Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages. J Lipid Res (1999) 1.02
High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. Arterioscler Thromb (1993) 1.01
Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Molecular size as a determinant of plasma lipoprotein influx. Arteriosclerosis (1981) 0.98
Effects of cytokines on the production of lipoprotein lipase in cultured human macrophages. J Lipid Res (1990) 0.98
A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Genet (1999) 0.96
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. J Lipid Res (2000) 0.96
Receptor-mediated mechanisms of lipoprotein remnant catabolism. Prog Lipid Res (1998) 0.94
A chemotactic S100 peptide enhances scavenger receptor and Mac-1 expression and cholesteryl ester accumulation in murine peritoneal macrophages in vivo. J Clin Invest (1995) 0.93
Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr Opin Lipidol (1994) 0.91
Effect of cholesterol feeding on arterial lipolytic activity in the rabbit. Atherosclerosis (1977) 0.88
Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women. Clin Genet (1999) 0.85
Modulation of lipoprotein lipase activity in mouse peritoneal macrophages by recombinant human tumor necrosis factor. Biochim Biophys Acta (1988) 0.83
Exposure to fatty acid increases human low density lipoprotein transfer across cultured endothelial monolayers. Circ Res (1985) 0.83
Endothelial cells and atherosclerosis: lipoprotein metabolism, matrix interactions, and monocyte recruitment. Curr Opin Lipidol (1994) 0.83
Lipoprotein lipase enhances the interaction of low density lipoproteins with artery-derived extracellular matrix proteoglycans. J Lipid Res (1993) 0.83
Regulation of lipoprotein lipase secretion by mouse peritoneal macrophages. Biochem Biophys Res Commun (1987) 0.78
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res (1984) 3.94
Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli. Methods Enzymol (1988) 3.60
Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products. Mol Cell Biol (1992) 2.51
Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol (2000) 2.50
Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol (1994) 1.91
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88
The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem (1997) 1.78
Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.73
The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res (1998) 1.73
Replication of human endothelial cells in culture. Science (1973) 1.72
Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J Biol Chem (2001) 1.72
Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics (1999) 1.60
Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest (2000) 1.59
Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest (1996) 1.59
Effect of aspirin on thrombin-induced adherence of platelets to cultured cells from the blood vessel wall. J Clin Invest (1978) 1.59
Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol (1998) 1.57
Mixing and bottling unit for preparing biological fluids used in quality control. Lab Pract (1975) 1.54
Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res (2001) 1.50
Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens (1999) 1.42
Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. J Clin Invest (1979) 1.39
Differential requirement for SLP-76 domains in T cell development and function. Immunity (2001) 1.36
Regulation of low density lipoprotein receptors by adrenocorticotropin in the adrenal gland of mice and rats in vivo. J Biol Chem (1980) 1.32
The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J Biol Chem (1994) 1.30
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest (1997) 1.29
Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol (1997) 1.29
Efficient liver-specific deletion of a floxed human angiotensinogen transgene by adenoviral delivery of Cre recombinase in vivo. J Biol Chem (1999) 1.28
Retinoic acid-mediated activation of the mouse renin enhancer. J Biol Chem (2000) 1.25
Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem (1996) 1.22
Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endothelium. Thromb Res (1979) 1.22
Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Circ Res (2001) 1.22
Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem (1994) 1.22
Glycoprotein 330, a member of the low density lipoprotein receptor family, binds lipoprotein lipase in vitro. J Biol Chem (1993) 1.20
Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice. Am J Physiol Renal Physiol (2001) 1.19
The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem (1995) 1.17
Utilization of arachidonic and linoleic acids by cultured human endothelial cells. J Clin Invest (1981) 1.14
Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS-deficient mice. Am J Physiol (1999) 1.12
Spectinomycin resistance due to a mutation in an rRNA operon of Escherichia coli. J Bacteriol (1983) 1.11
Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics (2000) 1.11
The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J Biol Chem (1995) 1.10
Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B100. J Biol Chem (1995) 1.09
Highly regulated cell type-restricted expression of human renin in mice containing 140- or 160-kilobase pair P1 phage artificial chromosome transgenes. J Biol Chem (1999) 1.09
Identification of cis elements in the cardiac troponin T gene conferring specific expression in cardiac muscle of transgenic mice. Circ Res (2000) 1.08
The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J Biol Chem (1992) 1.06
Appropriate tissue- and cell-specific expression of a single copy human angiotensinogen transgene specifically targeted upstream of the HPRT locus by homologous recombination. J Biol Chem (2000) 1.05
Munc18c regulates insulin-stimulated glut4 translocation to the transverse tubules in skeletal muscle. J Biol Chem (2000) 1.04
Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci U S A (1984) 1.03
Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure. Am J Physiol Heart Circ Physiol (2010) 1.01
Transactivation of the human renin promoter by the cyclic AMP/protein kinase A pathway is mediated by both cAMP-responsive element binding protein-1 (CREB)-dependent and CREB-independent mechanisms in Calu-6 cells. J Biol Chem (1997) 0.99
Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J Biol Chem (1994) 0.98
The angiotensinogen gene is expressed in both astrocytes and neurons in murine central nervous system. Brain Res (1999) 0.98
The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J Biol Chem (1995) 0.97
NF-Y antagonizes renin enhancer function by blocking stimulatory transcription factors. Hypertension (2001) 0.97
Expression of murine renin genes during fetal development. Mol Endocrinol (1990) 0.97
Vectors for high-level expression of cDNAs controlled by tissue-specific promoters in transgenic mice. Biotechniques (2001) 0.96
Species-specific differences in positive and negative regulatory elements in the renin gene enhancer. Circ Res (1999) 0.94
Hemangioma with thrombocytopenia and microangiopathic anemia (Kasabach-Merritt syndrome): an animal model. J Lab Clin Med (1971) 0.94
Receptor-mediated mechanisms of lipoprotein remnant catabolism. Prog Lipid Res (1998) 0.94
Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke (2000) 0.93
Conserved enhancer elements in human and mouse renin genes have different transcriptional effects in As4.1 cells. Circ Res (1997) 0.92
Utilization of long-chain free fatty acids by human platelets. J Clin Invest (1970) 0.91
Endogenous human renin expression and promoter activity in CALU-6, a pulmonary carcinoma cell line. Hypertension (1995) 0.91
Allele-specific expression of the murine Ren-1 genes. J Biol Chem (1989) 0.91
Platelet adherence to cultured vascular cells: influence of prostacyclin (PGI2). Blood (1980) 0.90
Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro. J Biol Chem (1996) 0.90
Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism. J Lipid Res (2000) 0.90
Effect of fatty acid modification on prostacyclin production by cultured human endothelial cells. J Clin Invest (1980) 0.89
Vascular biology in genetically altered mice : smaller vessels, bigger insight. Circ Res (2000) 0.89
Localization of free fatty acids taken up by human platelets. Blood (1972) 0.89
Interaction of thrombin and platelets with the vascular endothelium. Fed Proc (1980) 0.89
Genetic evidence that lethality in angiotensinogen-deficient mice is due to loss of systemic but not renal angiotensinogen. J Biol Chem (2000) 0.89
Expression of the DBA/2J Ren-2 gene in the adrenal gland of transgenic mice. EMBO J (1989) 0.88
Ligand size as a determinant for catabolism by the low density lipoprotein (LDL) receptor pathway. A lattice model for LDL binding. J Biol Chem (1991) 0.87
Biosynthesis of renin in mouse kidney tumor As4.1 cells. Eur J Biochem (1997) 0.87
JG cell expression and partial regulation of a human renin genomic transgene driven by a minimal renin promoter. Am J Physiol (1999) 0.87
Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ Res (1998) 0.87
Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B (B-46). N Engl J Med (1989) 0.86
Hemangioma, thrombocytopenia, and anemia. The Kasabach-Merritt syndrome in an animal model. Arch Pathol (1971) 0.86
Effect of free fatty acids on ADP-induced platelet aggregation. Nature (1970) 0.85
Increase in serum free fatty acids, phospholipids and reduction in total cholesterol in acute myocarditis produced by scorpion (Buthus tamulus) venom injection in dogs. Indian Heart J (1987) 0.85
The effects of glucocorticoids on cultured human endothelial cells. Br J Haematol (1978) 0.85
Transcriptional and posttranscriptional mechanisms regulate human renin gene expression in Calu-6 cells. Am J Physiol (1996) 0.85
Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro. J Biol Chem (1993) 0.85
Evidence for isomerization during binding of apolipoprotein-B100 to low density lipoprotein receptors. J Biol Chem (1992) 0.84
Effects of glucocorticoids on the interaction of lymphoblastoid cells with human endothelial cells in vitro. Cancer Res (1978) 0.84
Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. Am J Physiol (1999) 0.84
Regulation of human renin mRNA expression and protein release in transgenic mice. Hypertension (1996) 0.83
Understanding hypertension through genetic manipulation in mice. Kidney Int (2000) 0.83
Modifiable gene expression in mice: kidney-specific deletion of a target gene via the cre-loxP system. Exp Nephrol (1999) 0.82
gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex. J Cell Sci (1995) 0.82
Human renin mRNA stability is increased in response to cAMP in Calu-6 cells. Hypertension (1999) 0.82
Kidney is the only source of human plasma renin in 45-kb human renin transgenic mice. Circ Res (1999) 0.82
Very low density lipoproteins stimulate surfactant lipid synthesis in vitro. J Clin Invest (1997) 0.82
Transgenic mice for studies of the renin-angiotensin system in hypertension. Acta Physiol Scand (2004) 0.81
The carboxy-terminal domain of lipoprotein lipase induces cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Ann N Y Acad Sci (1994) 0.80